Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 314201 - 314220 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Lithuania | (L01FA01) rituximab | Ruxience 100 mg koncentratas infuziniam tirpalui 10 ml N1 (Pfizer Europe MA EEIG, Belgija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell;Arthritis, Rheumatoid;Microscopic Polyangiitis;Pemphigus | PfizerEuropeMAEEIG,Belgija |
| Lithuania | (L01FA01) rituximab | Ruxience 100 mg koncentratas infuziniam tirpalui 10 ml N1 (Pfizer Europe MA EEIG, Belgija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell;Arthritis, Rheumatoid;Microscopic Polyangiitis;Pemphigus | PfizerEuropeMAEEIG,Belgija |
| Lithuania | (L01FA01) rituximab | Rixathon 500 mg koncentratas infuziniam tirpalui 50 ml N1 (Sandoz GmbH, Austrija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Leukemia, Lymphocytic, Chronic, B-Cell;Wegener Granulomatosis;Microscopic Polyangiitis;Pemphigus | SandozGmbH,Austrija |
| Lithuania | (L01FA01) rituximab | Rixathon 500 mg koncentratas infuziniam tirpalui 50 ml N1 (Sandoz GmbH, Austrija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Leukemia, Lymphocytic, Chronic, B-Cell;Wegener Granulomatosis;Microscopic Polyangiitis;Pemphigus | SandozGmbH,Austrija |
| Lithuania | (L01FA01) rituximab | Ruxience 500 mg koncentratas infuziniam tirpalui 50 ml N1 (Pfizer Europe MA EEIG, Belgija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell;Arthritis, Rheumatoid;Microscopic Polyangiitis;Pemphigus | PfizerEuropeMAEEIG,Belgija |
| Lithuania | (L01FA01) rituximab | Ruxience 500 mg koncentratas infuziniam tirpalui 50 ml N1 (Pfizer Europe MA EEIG, Belgija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell;Arthritis, Rheumatoid;Microscopic Polyangiitis;Pemphigus | PfizerEuropeMAEEIG,Belgija |
| Lithuania | (L01FA03) obinutuzumab | Gazyvaro 1000 mg koncentratas infuziniam tirpalui N1 (Roche Registration GmbH, Vokietija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | RocheRegistrationGmbH,Vokietija |
| Lithuania | (L01FB01) inotuzumab ozogamicin | BESPONSA 1 mg milteliai infuzinio tirpalo koncentratui N1 (Pfizer Europe MA EEIG, Belgija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | PfizerEuropeMAEEIG,Belgija |
| Lithuania | (L01FC01) daratumumab | DARZALEX 20 mg/ml koncentratas infuziniam tirpalui 20 ml N1 (Janssen-Cilag International N.V., Belgija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagInternationalN.V.,Belgija |
| Lithuania | (L01FC01) daratumumab | DARZALEX 20 mg/ml koncentratas infuziniam tirpalui 5 ml N1 (Janssen-Cilag International N.V., Belgija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagInternationalN.V.,Belgija |
| Lithuania | (L01FC01) daratumumab | DARZALEX 1800 mg injekcinis tirpalas 15 ml N1 (Janssen-Cilag International N.V., Belgija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagInternationalN.V.,Belgija |
| Lithuania | (L01FD01) trastuzumab | Herzuma 150 mg milteliai infuzinio tirpalo koncentratui N1 (Celltrion Healthcare Hungary Kft., Vengrija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | CelltrionHealthcareHungaryKft.,Vengrija |
| Lithuania | (L01FD01) trastuzumab | Ogivri 150 mg milteliai infuzinio tirpalo koncentratui N1 (Biosimilar Collaborations Ireland Limited, Airija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | BiosimilarCollaborationsIrelandLimited,Airija |
| Lithuania | (L01FD01) trastuzumab | Ontruzant 150 mg milteliai infuzinio tirpalo koncentratui N1 (Samsung Bioepis NL B.V., Nyderlandai) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | SamsungBioepisNLB.V.,Nyderlandai |
| Lithuania | (L01FD01) trastuzumab | Trazimera 150 mg milteliai infuzinio tirpalo koncentratui N1 (Pfizer Europe MA EEIG, Belgija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | PfizerEuropeMAEEIG,Belgija |
| Lithuania | (L01FD01) trastuzumab | Trazimera 150 mg milteliai infuzinio tirpalo koncentratui N1 (Pfizer Europe MA EEIG, Belgija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | PfizerEuropeMAEEIG,Belgija |
| Lithuania | (L01FD01) trastuzumab | Zercepac 150 mg milteliai infuzinio tirpalo koncentratui N1 (Accord Healthcare S.L.U., Ispanija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | AccordHealthcareS.L.U.,Ispanija |
| Lithuania | (L01FD01) trastuzumab | Zercepac 150 mg milteliai infuzinio tirpalo koncentratui N1 (Accord Healthcare S.L.U., Ispanija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | AccordHealthcareS.L.U.,Ispanija |
| Lithuania | (L01FD01) trastuzumab | Zercepac 420 mg milteliai infuzinio tirpalo koncentratui N1 (Accord Healthcare S.L.U., Ispanija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | AccordHealthcareS.L.U.,Ispanija |
| Lithuania | (L01FD01) trastuzumab | Zercepac 420 mg milteliai infuzinio tirpalo koncentratui N1 (Accord Healthcare S.L.U., Ispanija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | AccordHealthcareS.L.U.,Ispanija |
Pages
